On January 10, 2024, Relay Therapeutics, Inc. closed the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.345 USD | +4.33% | +18.66% | -33.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.29% | 935M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it has received $30 million in funding